Evidence map›Paper›PMID 20675371›Full record

ArticleThe Journal of biological chemistry2010

Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype.

Ying Cao, Annamaria Szabolcs, Shamit K Dutta, Usman Yaqoob, Kumaravelu Jagavelu, Ling Wang, Edward B Leof, Raul A Urrutia, Vijay H Shah, Debabrata Mukhopadhyay

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Comparative Proteomic Analysis of Liver Tissues and Serum inInternational journal of molecular sciences · 2022
    Article
  9. Galectin 1-A Key Player between Tissue Repair and Fibrosis.International journal of molecular sciences · 2022
    Review
  10. The contribution of neuropilin-1 in the stability of CD4Immunity, inflammation and disease · 2022
    Article
  11. TGF-β superfamily co-receptors in cancer.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. TGF-β Signaling.Biomolecules · 2020
    Review
  16. Review
  17. Review
  18. Neuropilins in the Context of Tumor Vasculature.International journal of molecular sciences · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ying CaoDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Annamaria Szabolcs
Shamit K Dutta
Usman Yaqoob
Kumaravelu Jagavelu
Ling Wang
Edward B Leof
Raul A Urrutia
Vijay H Shah
Debabrata Mukhopadhyay
Mayo Clinic · USChildren's Research Hospital · JP

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
Molecular Mechanisms of Portal HypertensionR01DK059615 · NIDDK · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H. · 2002 to 2023
$6.4M
Distinct Pathways of VPF/VEGF ReceptorsR01HL070567 · NHLBI · MAYO CLINIC ROCHESTER · PI MUKHOPADHYAY, DEBABRATA · 2002 to 2014
$4.7M
Regulatory Pathways and Role of VPF/VEGF in Renal CancerR01CA078383 · NCI · MAYO CLINIC ROCHESTER · PI MUKHOPADHYAY, DEBABRATA · 2004 to 2019
$4.5M
TGF Beta Receptor DynamicsR37GM055816 · NIGMS · MAYO CLINIC ROCHESTER · PI LEOF, EDWARD B · 2009 to 2018
$3.6M
Mechanisms of Nitric Oxide Signaling in Vascular RemodelingR01HL086990 · NHLBI · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H. · 2008 to 2011
$1.5M
The Neurotransmitter dopamine and angiogenesisR01HL072178 · NHLBI · MAYO CLINIC ROCHESTER · PI MUKHOPADHYAY, DEBABRATA · 2003 to 2007
$1.5M
REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCERR29CA078383 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MUKHOPADHYAY, DEBABRATA · 1998 to 2002
$383k
NCI NIH HHS CA78383NCI NIH HHS R01 CA078383NCI NIH HHS R29 CA078383NHLBI NIH HHS HL072178NHLBI NIH HHS HL70567NHLBI NIH HHS R01 HL070567NHLBI NIH HHS R01 HL072178NHLBI NIH HHS R01 HL086990NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK052913NIDDK NIH HHS R01 DK059615NIGMS NIH HHS R37 GM055816
6 · The paper itself

Abstract

The transforming growth factor-beta (TGF-β) superfamily is one of the most diversified cell signaling pathways and regulates many physiological and pathological processes. Recently, neuropilin-1 (NRP-1) was reported to bind and activate the latent form of TGF-β1 (LAP-TGF-β1). We investigated the role of NRP-1 on Smad signaling in stromal fibroblasts upon TGF-β stimulation. Elimination of NRP-1 in stromal fibroblast cell lines increases Smad1/5 phosphorylation and downstream responses as evidenced by up-regulation of inhibitor of differentiation (Id-1). Conversely, NRP-1 loss decreases Smad2/3 phosphorylation and its responses as shown by down-regulation of α-smooth muscle actin (α-SMA) and also cells exhibit more quiescent phenotypes and growth arrest. Moreover, we also observed that NRP-1 expression is increased during the culture activation of hepatic stellate cells (HSCs), a liver resident fibroblast. Taken together, our data suggest that NRP-1 functions as a key determinant of the diverse responses downstream of TGF-β1 that are mediated by distinct Smad proteins and promotes myofibroblast phenotype.

Indexed as

ActinsAnimalsCell Line, TransformedFibroblastsGene Expression RegulationHepatic Stellate CellsHumansLiverMiceMice, KnockoutMyoblastsNeuropilin-1PhosphorylationSignal TransductionSmad Proteins, Receptor-RegulatedTransforming Growth Factor beta1ActinsNeuropilin-1Smad Proteins, Receptor-RegulatedTransforming Growth Factor beta1

Identifiers

PMID20675371
PMCPMC2951255
OpenAlexW2012260101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.